Ember LifeSciences
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$54M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ember LifeSciences is a cold chain technology company that provides self-refrigerated, cloud-based shipping solutions for the transport of temperature-sensitive pharmaceuticals and vaccines.
Sector
Mobility, Transportation & Logistics
Verticals
Pharma Supply Chain, Logistics Software, Supply Chain Tracking, Circular Economy, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ember LifeSciences Comparables
Compare Ember LifeSciences with similar companies based on industry and business-model similarity.
Ember LifeSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Early Stage VC | Mar 3, 2026 | ||||
| Series A | Dec 16, 2025 | ||||
| Early Funding | Feb 14, 2023 |
Ember LifeSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TDF Ventures | Series A |
| Carrier Ventures | Series A, Early Funding |
| Amgen Ventures | Series A |
| Sea Court Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 8, 3.1x the trailing average.
- Aug 20, 2026
Monthly visitors grew 97% MoM, reaching 3.4K.
Recent news
Latest coverage and updates
- hiresAug 11, 2026
Ember LifeSciences, Inc. hired James Braithwaite as Chief Product Officer on Aug 11th '26.
- is_developingJul 30, 2026
Ember LifeSciences, Inc. is developing pharmaceutical cold chain technologies on Jul 30th '26.
- partners_withJul 30, 2026
Ember LifeSciences, Inc. was planning to partner with Alfresa Corporation on Jul 30th '26.
- receives_financingJun 26, 2026
Ember LifeSciences, Inc. receives financing of $27M in Series A.
Ember LifeSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ember LifeSciences's valuation, stock price, and market status.
Is Ember LifeSciences a public or private company?
Ember LifeSciences is a private company.
What is the current stock price of Ember LifeSciences?
Ember LifeSciences is a private company with no public stock price. No recent secondary market data is available.
How much is Ember LifeSciences worth (valuation)?
Valuation information for Ember LifeSciences is not publicly available.
Can I buy Ember LifeSciences stock?
Ember LifeSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ember LifeSciences's last funding round?
Ember LifeSciences's most recent funding round was Series A on May 27, 2026.
Who are the main investors in Ember LifeSciences?
Key investors in Ember LifeSciences include TDF Ventures, Carrier Ventures, Amgen Ventures, Sea Court Capital.
Will Ember LifeSciences IPO soon?
No public IPO plans have been announced for Ember LifeSciences.
How can I track Ember LifeSciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ember LifeSciences's secondary market activity and sign up for updates.